Tiny implant could replace weekly Weight-Loss shots
NCT ID NCT07430059
Summary
This early-stage study is testing a small, under-the-skin implant that slowly releases the weight-management medication semaglutide. It will compare the safety and drug levels of this single 4-week implant against four weekly injections of the same drug. The goal is to see if the implant is a safe and convenient alternative for people with overweight or obesity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.